- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/02 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines
Patent holdings for IPC class C07D 217/02
Total number of patents in this class: 392
10-year publication summary
30
|
25
|
31
|
20
|
30
|
27
|
20
|
21
|
23
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alcon, Inc. | 5425 |
28 |
Aerie Pharmaceuticals, Inc. | 50 |
9 |
Bausch + Lomb Ireland Limited | 691 |
9 |
Pfizer Inc. | 3387 |
7 |
Centre National de La Recherche Scientifique | 10418 |
7 |
D. Western Therapeutics Institute, Inc. | 19 |
7 |
Universite de Montpellier | 985 |
7 |
The Regents of the University of California | 19918 |
5 |
Janssen Pharmaceutica N.V. | 3392 |
5 |
Abivax | 119 |
5 |
Institut Curie | 584 |
5 |
Bristol-myers Squibb Company | 4898 |
4 |
Merck Patent GmbH | 5831 |
4 |
Epizyme, Inc. | 370 |
4 |
Icahn School of Medicine at Mount Sinai | 946 |
4 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
4 |
The University of Queensland | 660 |
4 |
Fosun Orinove Pharmatech, Inc. | 13 |
4 |
Woolsey Pharmaceuticals, Inc. | 79 |
4 |
Allergan, Inc. | 2349 |
3 |
Other owners | 263 |